AIP Stock Overview
Engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Adcock Ingram Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R66.70 |
| 52 Week High | R73.96 |
| 52 Week Low | R51.15 |
| Beta | 0.36 |
| 1 Month Change | 1.65% |
| 3 Month Change | -4.39% |
| 1 Year Change | 21.27% |
| 3 Year Change | 30.20% |
| 5 Year Change | 29.09% |
| Change since IPO | 95.89% |
Recent News & Updates
Recent updates
Shareholders Will Probably Hold Off On Increasing Adcock Ingram Holdings Limited's (JSE:AIP) CEO Compensation For The Time Being
Nov 13
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Adcock Ingram Holdings Limited's (JSE:AIP) CEO For Now
Nov 17Adcock Ingram Holdings (JSE:AIP) Is Increasing Its Dividend To ZAR1.09
Aug 28Shareholder Returns
| AIP | ZA Pharmaceuticals | ZA Market | |
|---|---|---|---|
| 7D | -2.4% | 0.4% | 1.0% |
| 1Y | 21.3% | -10.4% | 13.6% |
Return vs Industry: AIP exceeded the ZA Pharmaceuticals industry which returned -10.3% over the past year.
Return vs Market: AIP exceeded the ZA Market which returned 13.6% over the past year.
Price Volatility
| AIP volatility | |
|---|---|
| AIP Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in ZA Market | 8.7% |
| 10% least volatile stocks in ZA Market | 2.6% |
Stable Share Price: AIP has not had significant price volatility in the past 3 months compared to the ZA market.
Volatility Over Time: AIP's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1890 | n/a | Andy Hall | www.adcock.co.za |
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services.
Adcock Ingram Holdings Limited Fundamentals Summary
| AIP fundamental statistics | |
|---|---|
| Market cap | R9.79b |
| Earnings (TTM) | R814.01m |
| Revenue (TTM) | R9.64b |
12.0x
P/E Ratio1.0x
P/S RatioIs AIP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AIP income statement (TTM) | |
|---|---|
| Revenue | R9.64b |
| Cost of Revenue | R6.46b |
| Gross Profit | R3.18b |
| Other Expenses | R2.37b |
| Earnings | R814.01m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.55 |
| Gross Margin | 33.02% |
| Net Profit Margin | 8.44% |
| Debt/Equity Ratio | 0% |
How did AIP perform over the long term?
See historical performance and comparisonDividends
4.5%
Current Dividend Yield51%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/18 01:59 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Adcock Ingram Holdings Limited is covered by 13 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dan Leech | BNP Paribas Securities (Asia) |
| Marcelle Jankelow | Citigroup Inc |
| Mark Wadley | Credit Suisse |